Species of coagulase-negative staphylococci isolated from urine specimens submitted from both 
The importance of Staphylococcus saprophyticus as a cause of acute cystitis in young females has been well documented (1, 4, 7, 21, 24) . Recognition of the pathogenicity of this coagulase-negative staphylococcus, together with the increasing significance of Staphylococcus epidermidis as a nosocomial pathogen, has highlighted the need for fuller species identification of the coagulase-negative staphylococci. S. saprophyticus is characterized by novobiocin resistance, but three other coagulase-negative staphylococcal species (S. cohnii, S. xylosus, and S. sciuri) are also novobiocin resistant (8) , and novobiocin-resistant S. epidermidis strains have been reported (7, 25) . In addition, some authors report the isolation of novobiocin-sensitive S. saprophyticus (12, 15, 26) . The present study was undertaken to characterize the features of bacteriuria with coagulase-negative staphylococci by correlating species identification by the biotyping schema of Kloos and Schleifer (8) and the International Committee on Systematic Bacteriology Subcommittee on the taxonomy of staphylococci and micrococci (5) recommendations with antimicrobial susceptibility and clinical features. In particular, the reliability of novobiocin susceptibility alone to distinguish S. saprophyticus from other coagulase-negative staphylococci in urinary tract isolates was examined.
MATERIALS AND METHODS
Bacterial strains studied. All gram-positive, catalasepositive, coagulase-negative cocci isolated in single culture in concentrations greater than or equal to 104 CFU/ml from urine specimens submitted from both outpatients and inpatients to the Clinical Microbiology Laboratory at the Health Sciences Centre in Winnipeg, Manitoba, from January, 1980, to February, 1981, were included in this study. When possible, clinical data including sex, age, hospital ward, inpatient or outpatient, and midstream or catheterized specimen were recorded for each isolate.
Microbiology tests. Urine specimens were plated on split plates of blood agar and MacConkey agar by the quantitative loop technique and incubated for 18 to 24 h. Gram-positive organisms were initially screened in the clinical laboratory for catalase and coagulase production, using standard techniques (11) . The ability of the organisms to utilize glucose aerobically or anaerobically (oxidation-fermentation reaction) was tested by the constricted tube method with Facklam's medium formulation (2), with tubes read as oxidative, fermen-tative, or no change after incubation at 37°C for 24 h. Strains which were oxidative or no change and novobiocin susceptible were tested for production of acid aerobically from glycerol in the presence of 0.4 ,ug of erythromycin per ml (20) to exclude micrococci. Nitrate reduction was tested by a standard technique (11) , and phosphatase activity, lysostaphin susceptibility, and hemolysis on bovine blood agar were performed as described previously by Kloos and Schleifer (8) . Carbohydrate utilization of nine sugars (sucrose, trehalose, fructose, galactose, mannitol, lactose, mannose, maltose, and xylose), using an agar plate method, was also tested as described by Kloos and Schleifer (8) , with the modification of a Steer-Foltz replicator (23) to inoculate the media. For selected isolates, trehalose utilization was further tested, using a standard liquid broth method (11) .
Antimicrobial susceptibility. Antimicrobial susceptibility testing was done in the clinical microbiology laboratory by a modified Kirby-Bauer disk method (17) . Organisms were grown in brain heart infusion broth for 3 h at 37°C, then diluted to a concentration of 10' CFU/ml, inoculated onto Mueller-Hinton agar, and incubated for 18 h at 37°C with antibiotic-containing disks, including penicillin (10 U), oxacillin (1 ,ug), erythromycin (15 ,ug) , cephalothin (30 ,ug), gentamicin (10 ,ug) , and clindamycin (2 pLg). The diameter of inhibition of growth of the organism was measured, and susceptibility was determined by predetermined breakpoints (11) .
For novobiocin susceptibility, a 5-p.g disk (Oxoid Ltd., Ottawa, Ontario) was used with a breakpoint zone diameter of 14 mm. All novobiocin-resistant isolates also had minimal inhibitory concentrations (MICs) determined by an agar dilution technique. Organisms were grown to 108 CFU/ml in Trypticase (BBL Microbiology Systems) soy broth, diluted to 107 CFU/ml, then inoculated, using a Steer-Foltz replicator, onto media containing twofold increasing concentrations of novobiocin. The MIC for the organism was the concentration of antimicrobial agent in the first dilution at which no growth occurred. Nineteen strains (13%) could not be classified as S. epidermidis or S. saprophyticus and were assigned to other coagulase-negative staphylococcal species (Table 2) . Identification of these strains by the biotyping system was frequently not clear-cut, with species often assigned on the basis of one characteristic when other characteristics formed an inconsistent pattern. For instance, S. haemolyticus was identified when hemolysis was present in strains which were not S. epidermidis or S. saprophyticus and could not clearly be assigned to any other species; nonhemolytic strains which were mannitol negative were classified as S. hominis and, if maltose negative, as S. simulans. Four strains (21%) which could not be classified as S. epidermidis or S. saprophyticus were novobiocin resistant. These novobiocin-resistant strains were 4 of 7 oxidative strains, whereas none of 12 fermentative strains was novobiocin resistant.
RESULTS

Characterization
Antimicrobial susceptibility. All 24 5. saprophyticus strains were susceptible to clindamycin, cephalothin, and gentamicin. One strain was resistant to penicillin, three to oxacillin, and four to erythromycin. The single penicillin-resistant strain was the only isolate resistant to more than one antimicrobial agent. In contrast, 73% of S. epidermidis strains were resistant to penicillin, 18% to oxacillin, 36% to erythromycin, 56% to clindamycin, and 15% to gentamicin. All strains were susceptible to cephalothin. Thirty-eight percent of strains were resistant to more than one organism. The 19 strains other than S. epidermidis or S. saprophyticus showed a resistance profile similar to that of S. epidermidis, with 32% of strains multiply resistant, 58% penicillin resistant, 21% oxacillin resistant, and 32% erythromycin resistant. The differences between S. saprophyticus and S. epidermidis in proportions of organisms susceptible to penicillin, clindamycin, gentamicin, and in multiply-resistant strains and the differences between S. saprophyticus and other non-S. epidermidis coagulasenegative staphylococci in penicillin susceptibility and proportions of multiply-resistant strains were significant (P < 0.04, chi-square analysis).
The agar dilution MIC for novobiocin was greater than or equal to 16 ,ug/ml for all S. saprophyticus isolates. The S. cohnii strain and the novobiocin-resistant S. haemolyticus and S. epidermidis strains had MICs similar to that for S. saprophyticus, but the two novobiocin-resistant S. hominis had MICs of only 4 ,ug/ml. Clinical correlations. S. saprophyticus bacteriuria and bacteriuria with any other coagulasenegative staphylococcus were clearly distinguished by the clinical setting (Table 3 ). S. saprophyticus was isolated from young female outpatients, whereas other coagulase-negative staphylococci were isolated from older inpatients with no sexual predominance, many of whom had underlying urological abnormalities, as evidenced by the proportion with indwelling catheters (50%), renal transplants (9.6%), or paraplegia (4.3%). These differences in age, proportion of outpatients, and catheter association remain significant when females alone are compared between the two groups.
Whereas the epidemiological features of bacteriuria with coagulase-negative staphylococci other than S. epidermidis or S. saprophyticus resemble those of S. epidermidis, the single S. cohnii strain was isolated from a young symptomatic female outpatient, a setting similar to S. saprophyticus isolation. Of the other novobiocin-resistant strains, the two S. hominis strains were isolated from catheterized inpatients, the S. haemolyticus strain was isolated from a young female outpatient who was a renal transplant recipient, and the resistant S. epidermidis strain was identified in a 71-year-old female outpatient on long-term prophylactic trimethoprim-sulfamethoxazole for recurrent urinary infections.
DISCUSSION
At our institution, S. epidermidis was the most common coagulase-negative staphylococcal species isolated from urine specimens, followed by S. saprophyticus. All other coagulasenegative staphylococci comprised less than 15% of the isolates. This distribution is comparable to that found for 66 strains reported by Marsik and Brake (12) , using the same biotyping system. John et al. (6) , also using the same biotyping system, did not find S. saprophyticus to be a major isolate, a difference likely reflecting different patient populations from whom specimens were submitted. Other reports of coagulasenegative staphylococci species identified in urinary tract isolates from hospital laboratories have used the Baird-Parker typing system (1, 13, 14, 22) or have identified only S. epidermidis and S. saprophyticus (26) , and these reports cannot be compared with our own (16) . The two most commonly isolated species, S. epidermidis and S. saprophyticus, were clearly differentiated by several characteristics. In our hands, trehalose utilization by the agar method was not a satisfactory differentiating test, although the broth technique did reliably differentiate these two species. Oeding and Digranes (18) have also reported difficulty with trehalose utilization on solid media. The reasons for this variation are not clear. One factor may be inoculum size, as a Steer-Foltz replicator would deliver a smaller inoculum than the streak plate method reported by Kloos and Schleifer (8) , with subsequent difficulty in identifying weak positives. The other coagulase-negative staphylococci isolated from urine were seldom as clearly identified as S. epidermidis or S. saprophyticus by the biotyping system, a difficulty recognized by certain other investigators (12, 18) examining other clinical isolates. Some of these difficulties in identification may be eliminated by the use of the recently introduced commercial test systems for the identification of staphylococci (10), although these require further assessment in the clinical laboratory.
We found novobiocin susceptibility for S. saprophyticus identification to have a sensitivity of 100%, a specificity of 96%, and a positive predictive value of 83%. Other investigators (4, 22) have also found novobiocin susceptibility to be a reliable differentiating characteristic. If novobiocin resistance alone were used as a presumptive test for identification of S. saprophyticus, 5 of 29 isolates among our strains would have been misidentified as S. saprophyticus. However, these novobiocin-resistant, coagulase-negative staphylococci which are not S. saprophyticus were, except for the S. cohnii isolate, identified in a clinical setting which permits their being distinguished from S. saprophyticus. We identified only one (1%) novobiocin-resistant S. epidermidis strain, a proportion similar to that reported by Hovelius et al. (4) for urinary tract isolates, although other reports suggest novobiocin-resistant S. epidermidis are isolated more frequently from blood or pus (4, 25).
Williams et al. (26) reported the identification of novobiocin-susceptible urinary tract isolates of S. saprophyticus, but did not identify their isolates beyond S. saprophyticus and S. epidermidis. Novobiocin-resistant S. saprophyticus strains were identified in all of the patients with symptomatic infection in their study, and the novobiocin-susceptible S. saprophyticus may, in fact, have been other species. Marsik and Brake (12) also reported 2 of 18 S. saprophyticus, at least one of which was a urinary tract isolate, to be novobiocin susceptible, but do not enlarge on this observation, and its significance is difficult to interpret. Other reports (3, 22) substantiate our observation that urinary tract isolates of S. saprophyticus are uniformly novobiocin resistant. Thus, identification of a novobiocin-susceptible, coagulase-negative staphylococcus in the urine reliably excludes S. saprophyticus.
S. saprophyticus, as we and other investigators (1, 4, 7, 21, 24) have shown, occupies an epidemiological niche distinct from all other coagulase-negative staphylococci. That is, it is isolated from young females with symptomatic urinary infection, who are otherwise healthy. The general susceptibility of this species to standard antimicrobial agents has also been reported by other investigators (7, 19) . Non-S. saprophyticus coagulase-negative staphylococci, by contrast, when isolated from the urine, are found in a nosocomial setting and are frequently multiply resistant. Individual species do not appear to be distinguishable by clinical features or antimicrobial susceptibility profile. Some infrequently isolated species such as S. cohnii, may, like S. saprophyticus, be true pathogens in the urinary tract, but further clinical correlation will be necessary to clarify this association. As bacteriuria with species other than S. saprophyticus is associated with common clinical features, routine identification of coagulase-negative staphylococcal urinary isolates for the clinical microbiology laboratory, beyond the identification of S. saprophyticus, would not appear to be clinically useful. Further identification of other species would, however, be of value in some circumstances, such as epidemiological investigations.
In summary, coagulase-negative staphylococci are isolated from urine specimens in two distinct settings, acute cystitis in young female outpatients, invariably due to S. saprophyticus, and in patients with underlying urological abnormalities or nosocomial acquisition for all other species. Novobiocin susceptibility provides a simple and reliable means for differentiation of S. saprophyticus from other coagulase-negative staphylococci in urine specimens. Further species identification as a routine procedure for urine specimens in the clinical microbiology laboratory would not appear to be clinically useful.
